AC Immune Says Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential As Neurodegenerative Disease Diagnostic
Portfolio Pulse from Benzinga Newsdesk
AC Immune has published clinical data in Nature Communications showing that its Alpha-Synuclein PET Tracer ACI-12589 has potential as a diagnostic tool for neurodegenerative diseases.
October 27, 2023 | 11:24 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AC Immune's published data on its Alpha-Synuclein PET Tracer ACI-12589 could potentially increase the company's value if the product is successfully commercialized.
The publication of positive clinical data on AC Immune's Alpha-Synuclein PET Tracer ACI-12589 in a reputable journal like Nature Communications is a significant development. If the product is successfully commercialized, it could potentially increase the company's value by providing a new revenue stream and strengthening its product portfolio.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100